Ghanbar Mahmoodi Chalbatani

Author

Tehran University of Medical Sciences ORCID

Also Known As

Ghanbar Chalbatani, Ghanbar Mahmoodi C, Ghanbar Mahmoodi Chalbatani

Publications

Citations

H-Index

Concepts

All Affiliations

Tehran University of Medical Sciences Shahid Beheshti University of Medical Sciences Motamed Cancer Institute Mashhad University of Medical Sciences University of Tehran

About

Ghanbar Mahmoodi Chalbatani is an author at Tehran University of Medical Sciences specializing in medicine, tumor microenvironment, and systems biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	2	2	39
2	Engineering	1	1	19
3	Health Sciences	1	1	20
4	Cell Biology	1	1	19
5	Pathology	1	1	19

Ghanbar Mahmoodi Chalbatani

Publications

612

Citations

H-Index

Page 1

	Year	Citations
Molecular Mechanisms and Biological Functions of siRNA Hassan Dana, Ghanbar Mahmoodi Chalbatani, Habibollah Mahmoodzadeh International Journal of Biomedical Science	2017	480
<p>In silico Analysis, Molecular Docking, Molecular Dynamic, Cloning, Expression and Purification of Chimeric Protein in Colorectal Cancer Treatment</p> Hassan Dana, Ghanbar Mahmoodi Chalbatani, Elahe Gharagouzloo, Drug Design Development and Therapy	2020	26
<p>Encapsulated Checkpoint Blocker Before Chemotherapy: The Optimal Sequence of Anti-CTLA-4 and Doxil Combination Therapy</p> Reza Aimohammadi, Razie Alibeigi, Amin Reza Nikpoor, International Journal of Nanomedicine	2020	26
Radiation dose and schedule influence the abscopal effect in a bilateral murine CT26 tumor model Haniyeh Ghaffari‐Nazari, Masoumeh Alimohammadi, Reza Alimohammadi, International Immunopharmacology Adaptive RadiotherapyRadiation MedicineAbscopal EffectRadiation TherapyMedicine	2022	20
Comprehensive analysis of ceRNA networks to determine genes related to prognosis, overall survival, and immune infiltration in clear cell renal carcinoma Ghanbar Mahmoodi Chalbatani, Seyed Ali Momeni, Mohammad Hosein Mohammadi Hadloo, Computers in Biology and Medicine EngineeringGenitourinary CancerMedicinePathologyCancer Genomics	2021	19
Dual blockage of both PD-L1 and CD47 enhances the therapeutic effect of oxaliplatin and FOLFOX in CT-26 mice tumor model Reza Alimohammadi, Ghanbar Mahmoodi Chalbatani, Masoumeh Alimohammadi, Scientific Reports	2023	16
The integrative multi-omics approach identifies the novel competing endogenous RNA (ceRNA) network in colorectal cancer Ghanbar Mahmoodi Chalbatani, Elahe Gharagouzloo, Mohammad Amin Malekraeisi, Scientific Reports	2023	14
Co-expression of PD-1 with TIGIT or PD-1 with TIM-3 on tumor-infiltrating CD8+ T cells showed synergistic effects on improved disease-free survival in treatment-naïve CRC patients Abdo Meyiah, Ghanbar Mahmoodi Chalbatani, Mohamed A. Al-Mterin, International Immunopharmacology	2023	11

Page 1